AI company Zebra Medical Vision has scored another approval from the FDA, this time for its AI alert that can help diagnose pneumothoraces based on chest X-rays.
Chief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable online platform that aims to make AI accessible to all drug discovery res
Less than a year after coming out of stealth mode with a $65 million first-round last year, artificial intelligence specialist Insitro has already signed its first biopharma partner.
The UK government’s Biomedical Catalyst (BMC) programme has announced £23 million of funding for cutting edge health projects, including new software which enables radiologists to diagnose
UK artificial intelligence (AI) drug discovery company Exscientia has agreed a three year drug discovery deal with Celgene, focusing on finding new cancer and autoimmune drugs.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
